These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 26238618)

  • 21. Advances in ovarian cancer proteomics: the quest for biomarkers and improved therapeutic interventions.
    Jurisicova A; Jurisica I; Kislinger T
    Expert Rev Proteomics; 2008 Aug; 5(4):551-60. PubMed ID: 18761466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mass spectrometry-based clinical proteomics: head-and-neck cancer biomarkers and drug-targets discovery.
    Matta A; Ralhan R; DeSouza LV; Siu KW
    Mass Spectrom Rev; 2010; 29(6):945-61. PubMed ID: 20945361
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of proteomics in prostate cancer research: biomarker discovery and validation.
    Pin E; Fredolini C; Petricoin EF
    Clin Biochem; 2013 Apr; 46(6):524-38. PubMed ID: 23266295
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proteomics as a probe of microbial pathogenesis and its molecular boundaries.
    Bhavsar AP; Auweter SD; Finlay BB
    Future Microbiol; 2010 Feb; 5(2):253-65. PubMed ID: 20143948
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Challenges of genomics and proteomics in nephrology.
    Stojnev S; Pejcic M; Dolicanin Z; Velickovic LJ; Dimov I; Stefanovic V
    Ren Fail; 2009; 31(8):765-72. PubMed ID: 19814648
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitative proteomic and genomic profiling reveals metastasis-related protein expression patterns in gastric cancer cells.
    Chen YR; Juan HF; Huang HC; Huang HH; Lee YJ; Liao MY; Tseng CW; Lin LL; Chen JY; Wang MJ; Chen JH; Chen YJ
    J Proteome Res; 2006 Oct; 5(10):2727-42. PubMed ID: 17022644
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proteomics makes progress in cartilage and arthritis research.
    Wilson R; Whitelock JM; Bateman JF
    Matrix Biol; 2009 Apr; 28(3):121-8. PubMed ID: 19379666
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proteomic analysis of multiple myeloma: current status and future perspectives.
    Ge F; Bi LJ; Tao SC; Xu XD; Zhang ZP; Kitazato K; Zhang XE
    Proteomics Clin Appl; 2011 Feb; 5(1-2):30-7. PubMed ID: 21280235
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proteomics-based identification of a group of apoptosis-related proteins and biomarkers in gastric cancer.
    Bai Z; Ye Y; Liang B; Xu F; Zhang H; Zhang Y; Peng J; Shen D; Cui Z; Zhang Z; Wang S
    Int J Oncol; 2011 Feb; 38(2):375-83. PubMed ID: 21165559
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proteomics in the diagnosis of hepatocellular carcinoma: focus on high risk hepatitis B and C patients.
    El-Aneed A; Banoub J
    Anticancer Res; 2006; 26(5A):3293-300. PubMed ID: 17094443
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The molecular make-up of a tumour: proteomics in cancer research.
    Kolch W; Mischak H; Pitt AR
    Clin Sci (Lond); 2005 May; 108(5):369-83. PubMed ID: 15831087
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proteomic applications of surface plasmon resonance biosensors: analysis of protein arrays.
    Yuk JS; Ha KS
    Exp Mol Med; 2005 Feb; 37(1):1-10. PubMed ID: 15761246
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Technology insight: the application of proteomics in gastrointestinal disease.
    Din S; Lennon AM; Arnott ID; Hupp T; Satsangi J
    Nat Clin Pract Gastroenterol Hepatol; 2007 Jul; 4(7):372-85. PubMed ID: 17607293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-throughput genomic technology in research and clinical management of breast cancer. Plasma-based proteomics in early detection and therapy.
    Davis MA; Hanash S
    Breast Cancer Res; 2006; 8(6):217. PubMed ID: 17184556
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical application of proteomics in breast cancer: state of the art and perspectives.
    Goncalves A; Bertucci F
    Med Princ Pract; 2011; 20(1):4-18. PubMed ID: 21160207
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical proteomics in breast cancer: a review.
    Gast MC; Schellens JH; Beijnen JH
    Breast Cancer Res Treat; 2009 Jul; 116(1):17-29. PubMed ID: 19082706
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proteomic approaches to the discovery of cancer biomarkers for early detection and personalized medicine.
    Honda K; Ono M; Shitashige M; Masuda M; Kamita M; Miura N; Yamada T
    Jpn J Clin Oncol; 2013 Feb; 43(2):103-9. PubMed ID: 23248327
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advances in gastric cancer research will light the way to control this cancer.
    de Assumpção PP; Burbano RR
    Chin J Cancer Res; 2022 Dec; 34(6):575-578. PubMed ID: 36714337
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Editorial: Novel therapeutic targets of gastric carcinogenesis: from basic research to drug development and clinical application.
    Niu C; Ren D; Liu BL
    Front Oncol; 2024; 14():1431520. PubMed ID: 38854722
    [No Abstract]   [Full Text] [Related]  

  • 40. Aberrant DNA-PKcs and ERGIC1 expression may be involved in initiation of gastric cancer.
    Wang FR; Wei YC; Han ZJ; He WT; Guan XY; Chen H; Li YM
    World J Gastroenterol; 2017 Sep; 23(33):6119-6127. PubMed ID: 28970727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.